

Add to Cart
Transcranial Magnetic Stimulation RTMS Machine For Brain Therapy
Neurocare Technology 810nm Infrared Brain Photobiomodulation Therapy Helmet
Compared with other therapy method, like drugs, light therapy is
the most safe and no side effects way for treatment.
Light therapy was known in medical field for a long time,
especially for the red light and infrared.
All our clients feel good spirit and comfortable after using.
Our device works with 810nm infrared, it can extend through the
skull into the brain, offers an unique array of neurological
benefits. It usually be used for treating metastatic lesions in
deep tissues as well as in bones. And also be used for cancer cell
imaging, as well as circulating tumor cell detection and
destruction.
1. The 810 nm wavelength has the ability to extend through the
skull to the brain, promoting recovery from traumatic brain injury
and reducing long-term nerve damage.
2. 810nm wavelength can help patients with severe depression and
anxiety
3. NIR light is absorbed by cytochrome C oxidase in mitochondria.
4. Increased blood flow, energy, neuroprotection and less
inflammation.
5. treat traumatic (stroke, TBI), neurodegenerative and psychiatric
diseases.
How often does a person use the helmet?
For long-term chronic diseases, such as degenerative diseases, the
recommended course of treatment is 3-6 months.
For short-term symptoms, such as concussion, migraine, depression,
etc., the recommended course of treatment is 1-3 months.
According to the severity of the patient’s symptoms, use 4-6 times
a week, 1-2 times a day. At the beginning of the treatment, it is
recommended to give the patient a process of adaptation. About the
power intensity and time, you can start from 25% , 12 minutes.
Gradually increase the power intensity and time step by step. After
a adapation period, can use 75-100% intensity for 24-30 minutes.
How long to set the timer?
You can choose 6 minutes – 12 minutes – 18 minutes – 24 minutes –
30 minutes
Are your infrared LEDs near infrared?
Our model is near infrared with 810nm.
Why do you use a mix of red LED and infrared LED? Why are they red?
We use 256pcs near infrared light for therapy. There are 4 pcs red
led for instruction, to show you the device is working. Sometimes
the near infrared is hardly to be seen from eyes, so the red light
just for instruction, not for therapy function.
Have you found that your machine is able to actually penetrate the
brain?
Yes, we have got a lot of research to prove this thoery which 810nm
light can penetrate the brian.
How deep have you seen your machines tested to penetrate through
the brain?
The 810nm light can penetrate our skull and works on nerve cell,
and there is Cytochrome C Oxidase inside the Mitochondria of the
cell, to promote the cell viability.
What frequency?
For the button model, the frequency is 40Hz, for the touch screen
model, the frequency is 1-20,000 Hz adjustable.
Introduction
Photobiomodulation (PBM) describes the use of red or near-infrared
light to stimulate, heal, regenerate, and protect tissue that has
either been injured, is degenerating, or else is at risk of dying.
One of the organ systems of the human body that is most necessary
to life, and whose optimum functioning is most worried about by
humankind in general, is the brain.
The brain suffers from many different disorders that can be
classified into three broad groupings: traumatic events (stroke,
traumatic brain injury, and global ischemia), degenerative diseases
(dementia, Alzheimer’s and Parkinson’s), and psychiatric disorders
(depression, anxiety, post traumatic stress disorder). There is
some evidence that all these seemingly diverse conditions can be
beneficially affected by applying light to the head. There is even
the possibility that PBM could be used for cognitive enhancement in
normal healthy people.
In this transcranial PBM (tPBM) application, near-infrared (NIR)
light is often applied to the forehead because of the better
penetration (no hair, longer wavelength).
PBM therapy was developed more than 50 years ago; however, there is
still no common agreement on the parameters and protocols for its
clinical application. Some research teams have recommended the use
of a power density of less than 100 mW/cm2 and an energy density of
4 to 10 J/cm2 [11]. Others groups recommend as much as 50 J/cm2 at
the tissue surface [11]. Parameters like wavelength, energy,
fluency, power, irradiance, pulse mode, treatment duration, and
repetition rate can be applied in a wide range. Our present
preliminary results showed a clear response of cerebral rSO2 in
relation to the LED stimulation. However, it has to be mentioned
that the temperature increased significantly, and these effects
have to be taken into account in further studies in detail. There
is also the fact that ineffective studies in cells with high
mitochondrial activity appear to be due more often to over-dosing
than to under-dosing [11]. Therefore, clinical studies concerning
the optimal stimulation doses are necessary.
Suggest Different Frequencies for Different kinds of Diseases
Disease | Treatment Time | Treatment Frequency |
Cerebral arteriosclerosis Insufficient, blood supply to the brain | 30 minutes | 50 Hz |
Brain atrophy | 30 minutes | 40-50 Hz |
Alzheimer’s disease (AD) | 30 minutes | 50 Hz |
Children with autism | 30 minutes | 10-30 Hz |
Cerebral thrombosis, Cerebral infarction | 30 minutes | 50 Hz |
Lacunar infarction | 30 minutes | 50 Hz |
Recovery of traumatic brain injury after operation | 30 minutes | 30 Hz |
The recovery period after cerebral poisoning | 30 minutes | 30-50 Hz |
Children with cerebral palsy | 20-30 minutes | 5-15 Hz |
Parkinson’s disease | 30 minutes | 30-50 Hz |
Depression | 20-30 minutes | 50 Hz |
Mental disorders | 20-30 minutes | 30-50 Hz |
Insomnia | 20-30 minutes | 5-15 Hz |
Nervous headache | 20-30 minutes | 20-40 Hz |
High blood pressure | 20-30 minutes | 5-15 Hz |
Brain fatigue disease | 20-30 minutes | 30 Hz |
Memory loss | 20-30 minutes | 30 Hz |
Neurasthenia | 20-30 minutes | 5-20 Hz |
Schizophrenia | 20-30 minutes | 5-20 Hz |
Specifications
Name | Brain Photobiomodulation Machine |
Model | GY-PDT1 |
LED Wavelength | 810 nm / 1070nm |
Led Quantity | 256pcs |
Power(total helmet) | 15 W |
Power(one LED) | 60 mW |
Power | 24 mW/cm2 |
Certificate | CE, FDA |
OEM | Support |
Color | White/Black |
Option Time | 6-12-18-24-30 minutes |
What is Photobiomodulation?
Photobiomodulation (PBM) describes the use of red or near-infrared
light to stimulate, heal, regenerate, and protect tissue that has
either been injured, is degenerating, or else is at risk of dying.
One of the organ systems of the human body that is most necessary
to life, and whose optimum functioning is most worried about by
humankind in general, is the brain. The brain suffers from many
different disorders that can be classified into three broad
groupings: traumatic events (stroke, traumatic brain injury, and
global ischemia), degenerative diseases (dementia, Alzheimer’s and
Parkinson’s), and psychiatric disorders (depression, anxiety, post
traumatic stress disorder). There is some evidence that all these
seemingly diverse conditions can be beneficially affected by
applying light to the head. There is even the possibility that PBM
could be used for cognitive enhancement in normal healthy people.
In this transcranial PBM (tPBM) application, near-infrared (NIR)
light is often applied to the forehead because of the better
penetration (no hair, longer wavelength).
Abstract:
A new piece of equipment for LED (light emitting diode) brain
photobiomodulation is introduced. Preliminary results from regional
cerebral oxygen saturation and from thermography are shown before,
during and after stimulation.
The procedure offers a new way to quantify the biological effects
of a possible innovative therapeutic method. However further
measurements are absolutely necessary.
The Brain Photobiomodulation Machine is a therapeutic instrument
based on the principle of photobiomodulation. It has a good
therapeutic effect on traumatic events (stroke, traumatic brain
injury, and global ischemia), degenerative diseases (dementia,
Alzheimer’s and Parkinson’s), and psychiatric disorders
(depression, anxiety, post traumatic stress disorder)
Brain photobiomodulation (PBM) with red to near-infrared (NIR)
light emitting diodes (LED) could be an innovative therapy for a
variety of neurological and psychological disorders. Red/NIR light
can stimulate mitochondrial respiratory chain complex IV
(cytochrome c oxidase) and increase ATP (adenosintriphosphate)
synthesis. In addition, light absorption by ion channels leads to
the release of Ca2+ and to the activation of transcription factors
and gene expression. Brain PBM therapy could improve the metabolic
capacity of neurons and is able to stimulate anti-inflflammatory,
anti-apoptotic and antioxidant responses as well as neurogenesis
and synaptogenesis. Findings suggest that PBM may enhance, for
example, the frontal brain functions of older adults in a safe and
cost-effective manner.
Note the increase in the regional cerebral oxygen saturation during
and after stimulation on the left and right side.
Results from thermal imaging of the first pilot measurement using
the new stimulation helmet. Note the increase in temperature on the
helmet (upper row; a before, b during, and c after stimulation) on
the forehead (middle row; d–f) and on the chin (lower row; g–i).
Main Function
1. The 810 nm wavelength has the ability to extend through the
skull to the brain, promoting recovery from traumatic brain injury
and reducing long-term nerve damage.
2. 810nm wavelength can help patients with severe depression and
anxiety
3. NIR light is absorbed by cytochrome C oxidase in mitochondria.
4. Increased blood flow, energy, neuroprotection and less
inflammation.
5. treat traumatic (stroke, TBI), neurodegenerative and psychiatric
diseases.
Indications
Contraindication
PBM therapy was developed more than 50 years ago; however, there is still no common agreement on the parameters and protocols for its clinical application. Some research teams have recommended the use of a power density of less than 100 mW/cm2 and an energy density of 4 to 10 J/cm2. Others groups recommend as much as 50 J/cm2 at the tissue surface. Parameters like wavelength, energy, flfluence, power, irradiance, pulse mode, treatment duration, and repetition rate can be applied in a wide range. Our present preliminary results showed a clear response of cerebral rSO2 in relation to the LED stimulation. However, it has to be mentioned that the temperature increased signifificantly, and these effects have to be taken into account in further studies in detail. There is also the fact that ineffective studies in cells with high mitochondrial activity appear to be due more often to over-dosing than to under-dosing. Therefore, clinical studies concerning the optimal stimulation doses are necessary.
Transcranial PBM appears promising to treat different mental
diseases. Pitzschke et al. also measured light propagation in
different areas of Parkinson’s disease (PD)-relevant deep brain
tissue during transcranial and transsphenoidal illumination (at 671
and 808 nm) of a cadaver head and modeled optical parameters of
human brain tissue using Monte-Carlo simulations. This study
demonstrates that it is possible to also illuminate deep brain
tissues transcranially and transsphenoidally. This opens
therapeutic options for sufferers of PD or other cerebral diseases
necessitating light therapy. There have been several investigations
concerning possible adverse effects for LED PBM.
For example, Moro et al. explored the effects of longer term
application, up to 12 weeks, of PBM (670 nm) in normal, naïve
macaque monkeys. They found no histological basis for any major
biosafety concerns associated with PBM delivered by an intracranial
approach. Hennessy and Hamblin also pointed out the already
established safety and notable lack of adverse effects of
transcranial PBM. The preliminary results are very promising;
however, further research work is required in order to be able to
use, for example, this new kind of PBM as a therapeutic method.
Many investigatorsbelieve that PBM with LED and/or laser for brain
disorders will become one of the most important medical
applications of light therapy in the coming years and decades.
Reference: Brain Photobiomodulation – Preliminary Results from
Regional Cerebral Oximetry and Thermal Imaging